EOM Pharmaceutical Holdings (EOM Pharmaceutical Holdings) Total Assets : $3.83 Mil (As of Jun. 2018)

View and export this data going back to 2006. Start your Free Trial

What is EOM Pharmaceutical Holdings Total Assets?

EOM Pharmaceutical Holdings's Total Assets for the quarter that ended in Jun. 2018 was $3.83 Mil.

Total Assets is connected with ROA %. EOM Pharmaceutical Holdings's annualized ROA % for the quarter that ended in Jun. 2018 was -27.31%. Total Assets is also linked to Revenue through Asset Turnover. EOM Pharmaceutical Holdings's Asset Turnover for the quarter that ended in Jun. 2018 was 0.00.

EOM Pharmaceutical Holdings Total Assets Historical Data

The historical data trend for EOM Pharmaceutical Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EOM Pharmaceutical Holdings Total Assets Chart

EOM Pharmaceutical Holdings Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Total Assets

Get a 7-Day Free Trial

28.94

25.18

30.08

16.89

7.01

EOM Pharmaceutical Holdings Quarterly Data
	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18
Total Assets	Get a 7-Day Free Trial															4.81	6.78	7.01	5.17	3.83

EOM Pharmaceutical Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

EOM Pharmaceutical Holdings's Total Assets for the fiscal year that ended in Dec. 2017 is calculated as

Total Assets	=	Total Equity (A: Dec. 2017 )	+	Total Liabilities (A: Dec. 2017 )
	=	4.648	+	2.361
	=	7.01

EOM Pharmaceutical Holdings's Total Assets for the quarter that ended in Jun. 2018 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2018 )	+	Total Liabilities (Q: Jun. 2018 )
	=	3.427	+	0.402
	=	3.83

EOM Pharmaceutical Holdings (OTCPK:IMUC) Total Assets Explanation

Total Assets is connected with ROA %.

EOM Pharmaceutical Holdings's annualized ROA % for the quarter that ended in Jun. 2018 is

ROA %	=	Net Income (Q: Jun. 2018 )	/	( (Total Assets (Q: Mar. 2018 )	+	Total Assets (Q: Jun. 2018 ))	/ count )
	=	-1.228	/	( (5.165	+	3.829)	/ 2 )
	=	-1.228	/	4.497
	=	-27.31 %

Note: The Net Income data used here is four times the quarterly (Jun. 2018) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

EOM Pharmaceutical Holdings's Asset Turnover for the quarter that ended in Jun. 2018 is

	Asset Turnover
=	Revenue (Q: Jun. 2018 )	/	( (Total Assets (Q: Mar. 2018 )	+	Total Assets (Q: Jun. 2018 ))	/ count )
=	0	/	( (5.165	+	3.829)	/ 2 )
=	0	/	4.497
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

EOM Pharmaceutical Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of EOM Pharmaceutical Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

EOM Pharmaceutical Holdings (EOM Pharmaceutical Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EOM Pharmaceutical Holdings Inc (OTCPK:IMUC) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

136 Summit Avenue, Suite 100, Montvale, NJ, USA, 07645

Website

https://www.eompharma.com

EOM Pharmaceutical Holdings Inc is focused on developing novel immunomodulatory and retinal disease drug agents to address a range of inflammatory, viral, retinal, and other diseases. Its product candidate includes dual-acting broad-spectrum immunomodulator EOM613, which has the potential to treat cancer cachexia and rheumatoid arthritis, and its advanced formulation of EOM147 is being studied to treat serious retinal diseases without the need for intraocular injection.

Executives

Andrew Gengos	director	21900 BURBANK BOULEVARD, 3RD FLOOR, WOODLAND HILLS CA 91367
Gary Titus	director, officer: Chairman and Secretary	SCICLONE PHARMACEUTICALS, INC., 950 TOWER LANE, SUITE 900, FOSTER CITY CA 94404-2125
Anthony Gregg Lapointe	director	PO BOX 83216, GAITHERSBURG MD 20883-3216
Mark A Schlossberg	director	C/O IMPAX LABORATORIES, INC., 30831 HUNTWOOD AVENUE, HAYWARD CA 94544
Rahul Singhvi	director	246 HOLLY DRIVE, CHALFONT PA 18914
Helen Susan Kim	director	3832 BAY CENTER PLACE, HAYWARD CA 94545
Richard Chin	director	C/O OXIGENE, INC., 230 THIRD AVENUE, WALTHAM MA 02451
Richard Cowell	director	7840 VIRGINIA OAK DRIVE, GAINSVILLE VA 20155
James G. Bender	officer: VP, Product Development & Mfg.	112 WEST 34TH STREET, 17TH FLOOR, NEW YORK NY 10120
Manish Singh	director, officer: President & CEO	21900 BURBANK BOULEVARD, 3RD FLOOR, WOODLAND HILLS CA 91367
Jacqueline Brandwynne	director	649 STONE CANYON ROAD, LOS ANGELES CA 90077